DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the market capitalisation of Evoq Remedies Ltd?

Evoq Remedies Ltd has a market capitalisation of approximately ₹6 crore.

Evoq Remedies Ltd

EVOQREMEDIESLTD·NSE·Commercial Services

₹0.00▲ +0.00 (+0.00%)

⚠️Trading suspended. Not a live price.

Commercial Services · Trading & Distributors

A steady, established business

52W₹2

₹6-54%

Open

—

High

—

Low

—

Prev Close

—

Volume

—

VWAP

—

Snapshot

Key fundamentals

Market Cap

₹6 Cr

P/E Ratio

N/A

P/B Ratio

0.13

EPS

₹0.04

Book Value

₹17.79

ROE

-0.54%Weak

ROCE

0.35%Weak

Dividend Yield

0.00%

Debt / Equity

0.00Low

Face Value

₹10.00

52W High

₹6.11

52W Low

₹2.14

Sector

Commercial Services

Industry

Trading & Distributors

Expensive

None moatHigh uncertainty

Fair value estimate

₹13

No recent traded price

BearFair valueBull

₹8₹13₹16

/100

Business quality — Watch the fundamentals

Growth 50Profitability 0Efficiency 0Valuation 100

Plain English

Our view

A steady, established business
Virtually debt-free balance sheet
Weak returns on equity (-1%)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

—

ROE

-0.5%Weak

Above 15% is considered healthy for Indian equities

ROCE

0.3%Weak

Above 18% means capital is working hard

Debt/Eq

0.00Low

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹6 Cr

P/B

0.13

EPS

₹0.04

Div Yield

—

What changed

Recent changes

Promoters-11.19% stake last quarter

What matters

News impact

Overview

Valuation

N/A

No P/E

Growth

Steady

+8% rev CAGR

Profitability

Loss-making

-0.5% ROE

Financial health

Rock solid

D/E 0.00

Momentum

N/A

No technicals

Today

Trading activity

Delivery %—

Turnover—

Trades—

VWAP—

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+7.8%

+20.6%

10Y

—

Profit

—

10Y

—

EPS

-46.7%

-81.0%

10Y

—

Profile

Pros

Company is almost debt free.
Stock is trading at 0.12 times its book value
Debtor days have improved from 160 to 55.1 days.

Watch-outs

Cons

Company has low interest coverage ratio.
Promoter holding has decreased over last quarter: -11.2%
Promoter holding is low: 0.02%
Company has a low return on equity of 0.29% over last 3 years.
Contingent liabilities of Rs.6.55 Cr.

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 31 Mar 2026

Promoters trimmed their stake by 11.19 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

Promoter

Promoters

0.0%-11.19

Public

94.6%+10.68

FII / FPI

0.0%0.00

DII

0.0%0.00

Others

5.4%

Total shareholders

1,655-24 QoQ

Quarterly trend

Ownership over time

Q4 FY26

Promoter0.02%

Public94.57%

Others5.41%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in 2010, EVOQ Remedies Ltd is in the pharmaceutical business.[1]